医学
丙氨酸转氨酶
慢性肝炎
血清转化
内科学
抗病毒治疗
胃肠病学
HBeAg
抗病毒治疗
丙氨酸转氨酶
免疫学
回顾性队列研究
病毒学
乙型肝炎病毒
乙型肝炎
病毒载量
丙氨酸
天冬氨酸氨基转移酶
病毒
药物治疗
免疫系统
作者
Fei Cao,Jian Wang,Ye Xiong,Ying Zhang,Xinrong Zhang,Tao Fan,Li Zhu,Shaoqiu Zhang,Zhiyi Zhang,Yifan Pan,Yuanyuan Li,Chao Jiang,Juan Xia,Yu Shi,Xiaomin Yan,Yuxin Chen,Xingxiang Liu,Chuanwu Zhu,Chao Wu,Rui Huang
标识
DOI:10.1080/22221751.2025.2589550
摘要
CHB patients with normal ALT levels had comparable VR rates but significantly lower rates of HBeAg clearance and seroconversion during first-line NA therapy than patients with elevated ALT levels.
科研通智能强力驱动
Strongly Powered by AbleSci AI